Different-Dose SCRT Plus CAPOX, PD-1 Blockade and IL-2 in LARC

Abroad (travel likely)RecruitingPHASE2

Conditions

Rectal Cancer · Radiotherapy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Jiangsu Province Hospital, Nanjing, Jiangsu, China
Contact: Study coordinator (Yueming Sun) · jssym@vip.sina.cn · 025-68306026

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer

Rectal Cancer · Total Neoadjuvant Therapy · Radiotherapy

Abroad (travel likely)RecruitingPHASE3

Wuhan, China

A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients

Colorectal Cancer

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China

Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)

Colorectal Cancer

Abroad (travel likely)RecruitingPHASE3

Amberg, Germany · Bad Saarow, Germany

Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases

Colorectal Cancer Metastatic · Liver Metastases · Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

New York, United States